What are the effects of anemia on digoxin pharmacokinetics and distribution? Are there any noted adverse outcomes in patients with anemia on digoxin?
Abstract
Anemia may reduce the efficacy of digoxin in achieving rate control, without a notable increase in adverse outcomes. Further research is needed to understand the specific pharmacokinetic effects.
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
Pharmacogenetics and Drug Metabolism
Heart Failure Treatment and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 February 2026
- Language
- EN